Skip to main content

Haptena Therapeutics

Turin, Italy

Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.

$3.5M raised
Dec 2025
Seed

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Haptena Therapeutics

How much funding has Haptena Therapeutics raised?
Haptena Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Who are Haptena Therapeutics's investors?
Haptena Therapeutics's investors include Claris Ventures.
Where is Haptena Therapeutics headquartered?
Haptena Therapeutics is headquartered in Turin, Italy.
What does Haptena Therapeutics do?
Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
What stage is Haptena Therapeutics at?
Haptena Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Haptena Therapeutics — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/haptena-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Haptena Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/haptena-therapeutics
Wikipedia (cite web)
{{cite web |title=Haptena Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/haptena-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .